×
Biodesix EBITDA 2020-2024 | BDSX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biodesix ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Biodesix EBITDA 2020-2024 | BDSX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Biodesix ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$98B
Cencora (COR)
$48.9B
DiDi Global (DIDIY)
$23.6B
ICON (ICLR)
$17.7B
Natera (NTRA)
$16.6B
Viatris (VTRS)
$15.5B
Avantor (AVTR)
$15.4B
Revvity (RVTY)
$14.9B
BioMerieux (BMXMF)
$13.1B
CochLear (CHEOY)
$12.6B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.3B
Charles River Laboratories (CRL)
$11B
Doximity (DOCS)
$10.8B
HealthEquity (HQY)
$8.6B
Sonic Healthcare (SKHHY)
$8.5B
Bausch + Lomb (BLCO)
$7B
Life Times (LTH)
$5.2B
Sotera Health (SHC)
$4.6B
Organon (OGN)
$4.1B
Surgery Partners (SGRY)
$3.9B
BrightSpring Health Services (BTSG)
$3.4B
PACS (PACS)
$3.3B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.9B